Rituximab Plus Avacopan Increases Remission Rates in ANCA-Associated Vasculitis
Anisha Dua, MD, MPH Credit: Convergence of the American College of Rheumatology Patients with antineutrophil cytoplasmic antibody (AAV)-associated vasculitis treated with rituximab (RTX) showed a significantly increased remission rate, which …